BriefTea
Every story in sixty words
Get the free app no ads · no paywallNews · 3 April 2026
AI Generated (Gemini)
Patients in Britain could gain greater access to life-extending treatments under the UK-US medicines deal. British pharmaceutical exports to the US will avoid tariffs for at least three years. However, critics warn NHS costs will rise sharply. Global Justice Now estimates the UK could spend an extra £9bn annually on medicines by 2035.
Reported by The Guardian · How we write briefs
Understand this story
Better NHS with AI?More briefs
TechnologyDisney to Hire Most of Bankrupt Character.AI's Staff PoliticsMiddlesbrough Named Hardest Place to Grow Up in England WorldDrone Attack Sets St Petersburg Oil Terminal on Fire, Killing One PoliticsPolice Investigate Reform Mayor Luke Campbell Over Alleged Naked Images SportsArsenal Beat Nottingham Forest 1-0 With Late Madueke Goal WorldIran says Hormuz will reopen if US meets conditions Browse all stories →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.